CSIRT Italia and CompuGroup Medical disclosed four vulnerabilities on November 4, 2026, across six products used by Italian pharmacies and physician practices: XDent, XMedical, Phronesis, Venere, Infantia and Profim. The flaws carry CVSS 4.0 scores of 8.0 and 8.1, and CompuGroup Medical says it found no evidence any of them were exploited.
The most direct is CVE-2026-118458, rated 8.1 and tracked as CWE-798, use of hard coded credentials. A shared login routine in Phronesis and Venere, the package cgm.it.ais.common, selects a test data access object left in production code and compares passwords in plaintext, which accepts a fixed administrator account regardless of what password a pharmacy or practice set. The flaw affects cgm.it.ais.common up to and including version 5.1.15.1.1.
CVE-2026-112172, also rated 8.1, hits XDent and XMedical before version 4.4.0. CompuGroup Medical's advisory describes PHP synchronization endpoints that unauthenticated attackers can reach to manipulate session variables and run arbitrary SQL queries against the backend MySQL databases. A dental practice running XDent and a physician office running XMedical share the same flawed code path.
Two more flaws hit a shared package across all four pharmacy products, Infantia, Profim, Venere and Phronesis. CVE-2026-118460, rated 8.0, found that embedded private keys protected by a shared password can sign practitioner assertions for arbitrary practitioner identifiers, which lets an attacker request unauthorized tokens in anyone's name. CVE-2026-118461, also rated 8.0, found that a shared client accepts caller controlled doctor identifiers for read and write operations with no authentication or authorization at all. Both affect the cgm.it.ais.farmaci package up to version 6.09.1 and cgm.it.ais.connector up to version 1.10.0.
CompuGroup Medical pushed fixes to every affected installation through its automatic update channel rather than waiting on manual patching, and it credited the researcher who reported the flaws through CSIRT Italia's coordinated disclosure process. Roberto Caramia, head of division at CSIRT Italia, said coordinated disclosure works when each party does its part, with the vendor shipping a fix before technical details reach the public.
Four products sharing one login routine and one key store means a single fix point, but it also means a single mistake reaches every pharmacy and practice running any of them. Practices that manage their own updates, rather than letting CGM's automatic channel handle it, are the ones still exposed.